Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

SYRESYRE
12 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in SPYRE THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.6M shares of SYRE (SPYRE THERAPEUTICS INC), worth $239.3M as of 2026-Q2. The position was increased (+48.9% shares). SYRE represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$239.3M

Current Shares

2.6M

Total Value Change

+$238.9M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+48.9%
$239.3M0.0%$88.78
42
2026-Q1
Increased
1.7M
+3.7%
$86.8M0.0%$40.07
31
2025-Q4
Increased
1.7M
+35.4%
$54.4M0.0%$31.88
38
2025-Q3
Decreased
1.2M
-0.2%
$20.5M0.0%$16.36
0
2025-Q2
Increased
1.2M
+15.8%
$18.4M0.0%$15.22
33
2025-Q1
Increased
1.1M
+9.7%
$17.1M0.0%$17.94
31
2024-Q4
Increased
966,129
+8.4%
$22.5M0.0%$22.54
31
2024-Q3
Increased
891,048
+16.4%
$26.2M0.0%$28.49
33
2024-Q2
Increased
765,834
+131.9%
$18M0.0%$23.51
46
2024-Q1
Increased
330,225
+988.9%
$12.5M0.0%$37.93
45
2023-Q4
Increased
30,326
+13.2%
$652,7690.0%$21.52
28
2023-Q3
New
26,800
-
$328,3960.0%$12.25
36

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used